BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

ZymoGenetics

ZymoGenetics has focused on the discovery, development, and commercialization of therapeutic proteins. Thanks to a robust discovery program, promising drug pipeline and strong development capabilities, ZymoGenetics is an emerging leader among biotherapeutic companies. The company has two products in advanced stage developement: rhThrombin and rFactor XIII

 

ZymoGenetics has also participated in the discovery or development of five recombinant protein products marketed by other companies for the treatment of various diseases, including diabetes, hemophilia, diabetic ulcer, gastrointestinal motility and severe hypoglycemia in diabetic patients treated with insulin and myocardial infarction or heart attacks.

 

CLINICAL TRIALS

 

More on Zymogenetics

Home page

Key Statistics for Zymogentics

Basic Chart for Zymogenetics

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com